KLRK1 and cancer: Since an upregulated expression of the activatory receptor NKG2D plays a crucial role in NK cell-mediated immunity against cancer [60], the downregulation of NKG2D in the early recurrence cohort could be a reflection of NK cell exhaustion [61].